Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Pain, Pollakiuria, Pyrexia
Clinical narrative: shaking; experienced fever; chills; a bright red rash on face; a bright red rash on face; uncontrollable urine; aching; cough; This is a spontaneous report received from contactable reporter(s) (Pharmacist).  A 81 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 12Nov2021 11:45 (Lot number: FD0809) at the age of 81 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Coronary Artery Disease" (unspecified if ongoing); "Kidney disease" (unspecified if ongoing); "Urinary Infection", stop date: Jan2011; "Pecans" (unspecified if ongoing), notes: Known allergies: Pecans. Concomitant medication(s) included: CLOPIDOGREL (ongoing); LISINOPRIL (ongoing); EXEMESTANE (ongoing); METOPROLOL TARTRATE (ongoing); AMLODIPINE (ongoing); EZETIMIBE (ongoing). Past drug history included: Haldol, reaction(s): "known allergies: Halodol"; Sulfa, notes: Known allergies: Sulfa. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9269, Route of Administration: Intramuscular), administration date: 03Mar2021, when the patient was 81 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EN5318, Route of Administration: Intramuscular), administration date: 10Feb2021, when the patient was 81 years old, for COVID-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 13Nov2021 03:00, outcome "recovered" (2021), described as "experienced fever"; CHILLS (non-serious) with onset 13Nov2021 03:00, outcome "recovered" (Nov2021), described as "chills"; RASH ERYTHEMATOUS (non-serious), RASH (non-serious) all with onset 13Nov2021 03:00, outcome "recovered" (Nov2021) and all described as "a bright red rash on face"; POLLAKIURIA (non-serious) with onset 13Nov2021 03:00, outcome "recovered" (Nov2021), described as "uncontrollable urine"; PAIN (non-serious) with onset 13Nov2021 03:00, outcome "recovered" (2021), described as "aching"; COUGH (non-serious) with onset 13Nov2021 03:00, outcome "recovered" (2021), described as "cough"; TREMOR (non-serious), outcome "recovered" (Nov2021), described as "shaking". Therapeutic measures were taken as a result of pyrexia, chills, rash erythematous, rash, pollakiuria, pain, cough, tremor.  Additional Information: About 12-15 hours post booster dose, patient experienced fever/chills, a bright red rash on face, uncontrollable urine, aching, and cough. Patient took tylenol and benadryl to alleviate symptoms. Symptoms resolved about 24-36 hours post onset. It was unknown that the patient had covid prior vaccination and not tested for Covid post vaccination. It was unknown that the patient received prior vaccination (within 4 weeks). Patient started experiencing chills, shaking and a red rash on her face approximately 12 hours post Injection. She also had trouble controlling her urine during this time as well. She took some Benadryl and her symptoms subsided around 36 hrs post Injection.  No follow-up attempts are possible. No further information is expected.